130 related articles for article (PubMed ID: 1964470)
1. Studies of pancreatic cancer utilizing monoclonal antibodies.
Büchler M; Friess H; Malfertheiner P; Schultheiss KH; Muhrer KH; Kraemer HP; Beger HG
Int J Pancreatol; 1990; 7(1-3):151-7. PubMed ID: 1964470
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer.
Büchler M; Friess H; Schultheiss KH; Gebhardt C; Kübel R; Muhrer KH; Winkelmann M; Wagener T; Klapdor R; Kaul M
Cancer; 1991 Oct; 68(7):1507-12. PubMed ID: 1654194
[TBL] [Abstract][Full Text] [Related]
3. Expression of the cell surface antigen detected by the monoclonal antibody A7 in pancreatic carcinoma cell lines.
Otsuji E; Yamaguchi T; Yamaguchi N; Koyama K; Imanishi J; Yamaoka N; Takahashi T
Surg Today; 1992; 22(4):351-6. PubMed ID: 1327320
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody for identification of human duct cell carcinoma of pancreas.
Parsa I; Sutton AL; Chen CK; Delbridge C
Cancer Lett; 1982; 17(2):217-22. PubMed ID: 6299513
[TBL] [Abstract][Full Text] [Related]
5. Isolation and immunohistochemical characterization of a pancreatic carcinoma-associated monoclonal antibody.
Halwani F; Cheung M; Jothy S
Exp Mol Pathol; 1990 Oct; 53(2):99-111. PubMed ID: 1702063
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization and serological immunoassay of a pancreatic carcinoma-associated antigen defined by monoclonal antibody LD-B1.
Halwani F; Jothy S
Exp Mol Pathol; 1990 Oct; 53(2):112-25. PubMed ID: 1702061
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody CO17-1A and leukapheresis in immunotherapy of pancreatic cancer.
Tempero MA; Pour PM; Uchida E; Herlyn D; Steplewski Z
Hybridoma; 1986 Jul; 5 Suppl 1():S133-8. PubMed ID: 3744378
[TBL] [Abstract][Full Text] [Related]
8. Production of three monoclonal antibodies specifically reactive respectively with the ductal, acinar and islet cells of the human pancreas.
Shibata K; Kobayashi T; Matsuura N; Shimano T; Mori T
Jpn J Clin Oncol; 1991 Feb; 21(1):13-21. PubMed ID: 1648632
[TBL] [Abstract][Full Text] [Related]
9. Human pancreatic adenocarcinoma-associated antigens defined by novel murine monoclonal antibodies Pak-1 and Pak-2.
Makisumi K; Takahashi K; Takako S; Sonoda S
Gastroenterol Jpn; 1990 Apr; 25(2):236-43. PubMed ID: 2161375
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemistry in pancreatic cancer with new monoclonal antibodies].
Kübel R; Büchler M; Baczako K; Beger HG
Langenbecks Arch Chir; 1987; 371(4):243-52. PubMed ID: 2830443
[TBL] [Abstract][Full Text] [Related]
11. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.
Metzgar RS; Gaillard MT; Levine SJ; Tuck FL; Bossen EH; Borowitz MJ
Cancer Res; 1982 Feb; 42(2):601-8. PubMed ID: 7034925
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of pancreatic carcinoma with the monoclonal antibody BW 494/32: first clinical results].
Friess H; Büchler M; Schulz G; Beger HG
Immun Infekt; 1989 Feb; 17(1):24-6. PubMed ID: 2925220
[TBL] [Abstract][Full Text] [Related]
13. Similarities in function between pancreatic tumor cells and macrophages and their inhibition by murine monoclonal antibodies.
Schorlemmer HU; Bosslet K; Kern HF; Sedlacek HH
Behring Inst Mitt; 1988 Apr; (82):240-64. PubMed ID: 3408453
[TBL] [Abstract][Full Text] [Related]
14. Murine monoclonal antibodies to human pancreatic cancer: specificity and sensitivity.
Jakowatz JG; Gan K; Ulich TR; Wile AG
Oncology; 1990; 47(2):149-54. PubMed ID: 2314827
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal carcinoma-associated antigen defined by a murine monoclonal antibody.
Chin JK; Rong GH; Scharff JE; Sindelar WF
J Natl Cancer Inst; 1986 Sep; 77(3):599-604. PubMed ID: 3528605
[TBL] [Abstract][Full Text] [Related]
16. [Development and clinical application of the monoclonal antibodies KM01-antibody and KM02-antibody for pancreatic cancer screening].
Ohyanagi H; Ishida T; Uesaka K; Yamamoto M; Okumura S; Saitoh Y; Uemura Y; Nishida M
Nihon Shokakibyo Gakkai Zasshi; 1985 Jul; 82(7):1748-55. PubMed ID: 2416971
[No Abstract] [Full Text] [Related]
17. [Immunotherapy of advanced pancreatic carcinoma with the monoclonal antibody BW 494].
Büchler M; Kübel R; Malfertheiner P; Friess H; Schulz G; Bosslet K; Beger HG
Dtsch Med Wochenschr; 1988 Mar; 113(10):374-80. PubMed ID: 3349938
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody-defined human pancreatic cancer-associated antigens.
Schmiegel WH; Kalthoff H; Arndt R; Gieseking J; Greten H; Klöppel G; Kreiker C; Ladak A; Lampe V; Ulrich S
Cancer Res; 1985 Mar; 45(3):1402-7. PubMed ID: 3882225
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of interferon gamma and monoclonal antibody 17-1A in pancreatic cancer: biologic and clinical effects.
Tempero MA; Sivinski C; Steplewski Z; Harvey E; Klassen L; Kay HD
J Clin Oncol; 1990 Dec; 8(12):2019-26. PubMed ID: 2121912
[TBL] [Abstract][Full Text] [Related]
20. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
Woodhouse CS; Morgan AC
Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
